Supplementary Table 8 contained within the Supplemental File (Tab 2) – Supplementary 9. Demographic & Clinical Characteristics of the Methylation Cohort Covariate No. % Clinical Site Cambridge 5 23 Karolinska 17 77 Sample Type Primary Tumour 20 91 Metastatic Disease 2 8 Class Label/Subgroup C1 8 36 C2 14 64 Gleason Score 6 2 9 7 4 18 8 9 41 9 7 32 Stage T2 5 23 T3 14 64 Unknown 3 13 Supplementary 10 contained within the Supplemental File (Tab 3) – Supplementary Table 11 contained within the Supplemental File (Tab 4) – contained within the Supplemental File (Tabs 5 & 6) Supplementary Table 12 –
Supplementary Table 8 – contained within the Supplemental File (Tab 2) Supplementary 9. Demographic & Clinical Characteristics of the Methylation Cohort Covariate No. % Clinical Site Cambridge 5 23 Karolinska 17 77 Sample Type Primary Tumour 20 91 Metastatic Disease 2 8 Class Label/Subgroup C1 8 36 C2 14 64 Gleason Score 6 2 9 7 4 18 8 9 41 9 7 32 Stage T2 5 23 T3 14 64 Unknown 3 13 Supplementary 10 – contained within the Supplemental File (Tab 3) Supplementary Table 11 – contained within the Supplemental File (Tab 4) Supplementary Table 12 – contained within the Supplemental File (Tabs 5 & 6)
REF%20EURUROL-D-16-01757%202nd%20Re-submission%20%28MARK-UP%29.docx